Jacobs Levy Equity Management, Inc Pfizer Inc Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $414,883 - $592,778	-15,349 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $505,289 - $573,438	15,349 New	15,349 $601,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $531,525 - $583,968	-14,174 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $545,273 - $621,671	14,174 New	14,174 $619,000

3,239

3.6B

77.1M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.